Press Release Details

JELD-WEN Employees Improve Health, Reduce Costs With Quest Diagnostics' Lifestyle-Health Assessment, Blueprint For Wellness(TM


TETERBORO, N.J., July 17 /PRNewswire/ -- JELD-WEN, one of the world's largest manufacturers of doors, windows, millwork and specialty wood products, is offering employees and their spouses a chance to improve their health and reduce their health care costs by participating in Blueprint for Wellness, a comprehensive lifestyle and health assessment offered by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services.

Under an agreement between JELD-WEN and Quest Diagnostics' Corporate Health and Wellness business unit, approximately 20,000 JELD-WEN employees and their spouses in the U.S. are eligible to participate in Blueprint for Wellness at health fairs that began in June and will continue through August at JELD-WEN facilities. The Blueprint for Wellness program provides confidential health improvement recommendations to participants based on a combination of lab results and self-reported data. Individuals who participate receive an individualized health risk assessment report sent directly to their homes.

"We strongly believe that employees who actively manage their own health are healthier, happier and more productive," said Jennifer Johns, Wellness Manager for JELD-WEN, whose North American headquarters are in Klamath Falls, Oregon. "Our facilities are spread out across the country. Quest Diagnostics' Blueprint for Wellness program provides the opportunity to reach everyone, even in remote locations, with quality health information."

Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services with annual revenues of $3.4 billion in 2000. The company's diagnostic testing yields information that enables health care professionals and consumers to make better decisions to improve health. Quest Diagnostics offers patients and physicians the broadest access to diagnostic testing services through its national network of approximately 30 full-service laboratories, 150 rapid response laboratories and more than 1,300 patient service centers, where specimens are collected. Quest Diagnostics is the leading provider of esoteric testing, and is the leader in routine medical testing, drugs of abuse testing, and anatomic pathology testing. Through partnerships with pharmaceutical, biotechnology and information technology companies, Quest Diagnostics provides support to help speed the development of health care insights and new therapeutics. Additional information can be found on the Internet at:

SOURCE Quest Diagnostics Incorporated

CONTACT: Media - Gary Samuels, +1-201-393-5700, or Investors - Cathy Doherty, +1-201-393-5030, both for Quest Diagnostics Incorporated/